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Abstract:  Triazole medicines are mainstream of the antifungal medicines, especially 
used in curing deep department fungal infections and its important intermediate is 
1-(4-hydroxylphenyl)-4-(4-nitrophenyl)piperazine. As the key intermediate of 
antifungal medicines of new generation,it has already caused international interest. A 
general and convenient synthesis of 1-(4-hydroxylphenyl)-4-(4-nitrophenyl) 
piperazine without the use of catalyst is described. 
Key words:  1-(4-hydroxylphenyl)-4-(4-nitrophenyl)piperazine; antifungal 
intermediate;  Triazole 
 
 
1.  INTRODUCTION 
 
1-(4-hydroxylphenyl)-4-(4-nitrophenyl)piperazine 1(Fig. 1.) (D. J. Sheehan, C. A. Hitchcock & C. M. 
Sibley, 1999) is a key moiety of a large number of triazole antifungals,These triazoles belong to the class 
of a widely used orally active broad-spectrum antifungals.Triazole medicines are mainstream of the 
antifungal medicines, especially in curing deep fungal infection and fungal infection of AIDS at present. 
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In the past 20 years, incidence of deep fungal infection has been on the rise apprently. These new 
medicine is not only safe and durable, but also useful in various kinds of fungal infection, which gives us 
a new choice to defend and cure the deep fungal infection. Members of this class are,for 
instance,Sch45009 2, Sch45012 3, Itraconazole 4,saperconazole 5,hydroxyitraconazole 6,Sch50001 
7,Sch50002 8,Sch51048 9, Pasaconzole 10。All of members above contain the unsymmetrically 
N,N-diarylated piperazine moiety(Fig. 2.) (F. Bennett et al, 2006; R. G. Lovey, 2002; A. K. Saksena, 
2004; J. S. Tkacz & B. DiDomenico, 2001; H. A. Torres, R. Y. Hachem, R. F. Chemaly, D. P. 
Kontoyiannis & I. I. Raad, 2005; A. K. Saksena, 1996) 
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Figure 1.   1-(4-hydroxylphenyl)-4-(4-nitrophenyl)piperazine 
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Figure 2.  Structures of triazole antifungals 
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Classical synthetic routes to the unsymmetrically N,N'-diarylated piperazine moiety 1 encompass the 
reaction of anilines with bis(2-chloroethyl)amine directly (K. G. Liu & A. J. Robichaud, 2005),or 
prepared via an SNAr reaction of piperazine with aryl halides containing electron-withdrawing groups to 
the mono N-aryl piperazine which are then reacted with appropriate arylhalides (T. Cohen, A. G. Dietz Jr, 
J. R. Miser & J. R. Miser,J., 1977; D. M. T. Chan, K. L. Monaco, R.-P.Wang & M. P. Winters, 1998). 
Alternatively, 1 can also be .generated in situ from diethanolamine (Z. Budai, T. Galambos & T. Mezei, 
1993). Overall the preparation of 1 can be divided into two major steps:the first step is the preparation of 
N-arylated piperazine which then convert into N,N'-diarylated piperazine with appropriate aryhalides in 
the second step. 
We developed a route to obtain the desire product 1 in three steps.First 1-(4-methoxyphenyl) 
piperazine were generated in situ from diethanolamine using one-pot synthesis 
method.1-(4-methoxyphenyl)piperazine react with p-chloronitrobenzene to synthesize 
1-(4-methoxyphenyl)-4-(nitrophenyl) piperazine by N-arylation. Then demethoxy to synthesize the key 
antifungal intermediate. 
 
2.  EXPERIMENT 
 
General procedure:With the presence of 0.26mol diethanolamine,360ml HBr(0.5mol)is slowly added 
into the flask over an hour.After complete addition, the reaction mixture is stirred and refluxed for 12 h. 
The reaction mixture is distilling off the excessed HBr which could be recycled.The crude product 
followed by its reaction with p-anisidine, without isolation treatment,can be carried out in one pot to 
obtain 1-(4-methoxyphenyl) piperazine in order to avoid purification carcinogenic 
bis(2-chloroethyl)amine. 
In an atmosphere of dry N2, a mixture of p-anisidine (0.24 mol), sodium carbonate(0.16mol)and 
80ml 1-butanol is added into the same flask and heated at 120ºC for 5 h.Another sodium 
carbonate(0.13mol) is added and continue to heat for 24h..After being cooled to room temperature, the 
suspension washes twice with 100ml water.The pH is adjusted to12 by the addition of sodium 
hydroxide,the suspension washes by saturated salt water.After the pH of the combined organic layers are 
adjusted to 5 by  the addition of about 30ml concentrated HCl. Water and 1-butanol is distilled to provide 
HCl salt. The HCl salt is dissolved in ethanol to recrystallize.The product is dried under vacuum at 100ºC 
to constant weight.(Scheme 1.) 
Yield:23.5g(37%) 
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Scheme 1 
 
A mixture of 0.07mol 1-(4-methoxyphenyl) piperazine dihydrochloride,0.073mol 
1-chloro-4-nitrobenzene,0.12mol potassium carbonate ,50ml N,N-Dimethylformamide is stirred and 
refluxed for 24h at 110ºC.After complete conversion, the reaction mixture is diluted with water and the 
product is extracted twice with trichloromethane.The combined extracts are dried,filtered and 
evaporated.The residue is triturated in 4-methyl-2-pentanone. The product is filtered off and crystallized 
from 1,4-dioxane.The product is dried under vacuum at 100ºC to constant weight (H. Jan & L. J. J. 
Backx, 1980). (Scheme 2.) 
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Yield:16.3g(74.4%) 
NN OCH3H
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NO2Br
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Scheme 2 
 
1-(4-methoxyphenyl)-4-(nitrophenyl) piperazine is then converted to the desired antifungal 
intermediate via demethylation.However demethylation requires an excess of refluxing aqueous HBr for 
prolonged period of time.In an atmosphere of dry N2, With the presence of 
0.014mol1-(4-methoxyphenyl)-4-(nitrophenyl) piperazine a mixture of 40mlHBr and acetic anhydride 
with the same volume is slowly added.After complete addition, the reaction mixture is stirred and 
refluxed for 12 h.at 140ºC.After the excessed HBr is distilled,The residue is washed by cold water then 
filtered off.The yellow crystals are dried under vacuum at 100ºC to constant weight.(Scheme 3.) 
Yield:1.9g(44.2%) 
HBrN N NO2H3CO N N NO2HO
Scheme 3 
 
3.  CONCLUSIONS 
 
In summary, we have developed a general and convenient procedure for the synthesis of 
1-(4-hydroxylphenyl)-4-(4-nitrophenyl)piperazine from anilines using diethanolamine in the absence of 
catalyst and high reaction temperature. 
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